Pronethalol
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
54-80-8 |
| PubChem (CID) | 4930 |
| ChemSpider | 4761 |
| UNII |
XBP4RT1IMQ |
| ChEMBL | CHEMBL16476 |
| ECHA InfoCard | 100.237.125 |
| Chemical and physical data | |
| Formula | C15H19NO |
| Molar mass | 229.32 g/mol |
| 3D model (Jmol) | Interactive image |
| Chirality | Racemic mixture |
| |
Pronethalol (Alderlin, Nethalide) was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite.[1]
See also
References
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
